Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial

被引：0
|
作者：
Prasse, A. [1 ]
Maher, T. M. [2 ,3 ]
Jenkins, R. G. [4 ]
Cottin, V [5 ]
Nishioka, Y. [6 ]
Noth, I [7 ]
Selman, M. [8 ]
Song, J. W. [9 ]
Ittrich, C. [10 ]
Diefenbach, C. [10 ]
Rohr, K. B. [11 ]
Stowasser, S. [11 ]
White, E. S. [12 ]
机构：
[1] MHH Hannover Med Sch, Dept Resp Med, Hannover, Germany
[2] Imperial Coll London, Natl Heart & Lung Inst, London, England
[3] Royal Brompton Hosp, Natl Inst Hlth Res Clin Res Facil, London, England
[4] Nottingham Univ Hosp, Natl Inst Hlth Res Resp Biomed Res Ctr, City Campus, Nottingham, England
[5] Claude Bernard Lyon 1 Univ, Louis Pradel Hosp, Natl Reference Ctr Rare Pulm Dis, Dept Resp Dis, Lyon, France
[6] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan
[7] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
[8] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico
[9] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea
[10] Boehringer Ingelheim Pharma GmbH & Co Kg, Biberach, Germany
[11] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[12] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P172
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [21] Defining and predicting progression in non-IPF interstitial lung disease
    Goos, Tinne
    De Sadeleer, Laurens J.
    Yserbyt, Jonas
    De Langhe, Ellen
    Dubbeldam, Adriana
    Verbeken, Erik K.
    Verleden, Geert M.
    Vermant, Marie
    Verschakelen, Johny
    Vos, Robin
    Weynand, Birgit
    Verleden, Stijn E.
    Wuyts, Wim A.
    RESPIRATORY MEDICINE, 2021, 189
  • [22] Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial Design
    Venuto, Charles S. S.
    Smith, Greta
    Herbst, Konnor
    Zielinski, Robert
    Yung, Norman C. W.
    Grosset, Donald G. G.
    Dorsey, E. Ray
    Kieburtz, Karl
    MOVEMENT DISORDERS, 2023, 38 (10) : 1774 - 1785
  • [23] Assessment of blood biomarkers in patients with IPF under antifibrotic therapy
    Wolf, Peter
    Schneider, Marc
    Muley, Thomas
    Meister, Michael
    Herth, Felix
    Kreuter, Michael
    Kahn, Nicolas
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Lactate dehydrogenase predicts disease progression in patients with IPF
    Hoyer, Nils
    Andersen, Michael Brun
    Collatz, Lene
    Attingsberg, Emilia Kassandra Achilles
    Shaker, Saher Burhan
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [25] Blood KL-6 Predicts Disease Progression in IPF Patients Receiving Antifibrotic Therapy
    Choi, M.
    Song, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] BIOMARKERS CAN PREDICT DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS: ANALYSIS FROM THE AUSTRALIAN IPF REGISTRY
    Jo, Helen E.
    Corte, Tamera J.
    Glaspole, Ian
    Grainge, Christopher
    Goh, Nicole
    Hopkins, Peter Ma
    Reynolds, Paul N.
    Chapman, Sally
    Walters, E. Haydn
    Zappala, Christopher
    Allan, Heather
    Keir, Gregory J.
    Hayen, Andrew
    Cooper, Wendy A.
    Mahar, Annabelle M.
    Ellis, Samantha
    Macansh, Sacha
    Moodly, Yuben
    RESPIROLOGY, 2017, 22 : 78 - 78
  • [27] Biomarkers Can Predict Disease Progression In Idiopathic Pulmonary Fibrosis: Analysis From The Australian Ipf Registry
    Jo, H. E.
    Corte, T. J.
    Glaspole, I.
    Grainge, C.
    Goh, N. S.
    Hopkins, P.
    Reynolds, P.
    Chapman, S.
    Walters, E. H.
    Zappala, C.
    Allan, H.
    Keir, G.
    Hayen, A.
    Cooper, W.
    Mahar, A.
    Ellis, S.
    Macansh, S.
    Moodley, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [28] Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry
    Jo, Helen
    Glaspole, Ian
    Grainge, Christopher
    Goh, Nicole
    Hopkins, Peter
    Moodley, Yuben
    Reynolds, Paul
    Chapman, Sally
    Walters, Hayd N.
    Zappala, Christopher
    Allan, Heather
    Keir, Gregory
    Hayen, Andrew
    Cooper, Wendy
    Mahar, Annabelle
    Ellis, Samantha
    Macansh, Sacha
    Corte, Tamera
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] Vimentin serum biomarkers are differentially related to disease progression in idiopathic pulmonary fibrosis (IPF)
    Simoes, Filipa B.
    Hoyer, Nils
    Prior, Thomas S.
    Jessen, Henrik
    Fredriksen, Peder
    Karsdal, Morten
    Leeming, Diana J.
    Bendstrup, Elisabeth
    Sand, Jannie M. B.
    Shaker, Saher B.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] PERFORMANCE OF CIRCULATING BIOMARKERS FOR PREDICTING PROGRESSION OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Yomono, K.
    Kuwana, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1618 - 1618
12345